FDA looks to work with more out­side agen­cies for in­spec­tions as it en­ters in­to an agree­ment for in­spec­tions with Switzer­land

The FDA is seek­ing more col­lab­o­ra­tions with dif­fer­ent glob­al agen­cies when it comes to in­spec­tions.

The agency re­cent­ly inked an agree­ment with the Swiss Agency for Ther­a­peu­tic Prod­ucts, or Swissmedic, to be an equiv­a­lent au­thor­i­ty in de­ter­min­ing good man­u­fac­tur­ing prac­tices. The agree­ment be­tween the two agen­cies al­lows for the ex­change of of­fi­cial doc­u­ments be­tween the FDA and Swissmedic, and clears the way for them to lever­age each oth­er’s in­spec­tion re­sources for man­u­fac­tur­er over­sight.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER